TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Weight Management in Obese Pregnant Underserved African American Women
Brief Summary: This project will test a novel lifestyle intervention to help overweight and obese socioeconomically disadvantaged African American women achieve healthy weight control during and after pregnancy and improve the health of their offspring. The treatment will be given through an existing national home visiting program, Parents As Teachers (PAT), which will facilitate sustainability and nationwide dissemination, if effective. We hypothesize that compared with standard PAT monitoring and counseling (PAT), women randomized to the lifestyle intervention program (PAT+) will have a lower percentage who exceed Institute of Medicine recommendations for gestational weight gain.


Options:
A: Arm Label: Parents As Teachers + Lifestyle Int.; Type: EXPERIMENTAL; Interventions: Behavioral: Parents As Teachers Plus (PAT+) | Arm Label: Standard Parents as Teachers (PAT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Parents As Teachers (PAT) | Intervention Type: BEHAVIORAL; Name: Standard Parents As Teachers (PAT); Assigned to Arm(s): Standard Parents as Teachers (PAT) | Intervention Type: BEHAVIORAL; Name: Parents As Teachers Plus (PAT+); Assigned to Arm(s): Parents As Teachers + Lifestyle Int.
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Therapeutic education | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Follow-up | Intervention Type: OTHER; Name: Therapeutic education; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Follow-up; Assigned to Arm(s): 2
C: Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Arm Label: Weight Management Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Management | Intervention Type: BEHAVIORAL; Name: Weight Management; Assigned to Arm(s): Weight Management Counseling | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: Nutritional counseling & self blood glucose monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: nutritional counseling, Behavioral: self blood glucose monitoring | Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: nutritional counseling; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring | Intervention Type: BEHAVIORAL; Name: self blood glucose monitoring; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Weight Management in Obese Pregnant Underserved African American Women
Brief Summary: This project will test a novel lifestyle intervention to help overweight and obese socioeconomically disadvantaged African American women achieve healthy weight control during and after pregnancy and improve the health of their offspring. The treatment will be given through an existing national home visiting program, Parents As Teachers (PAT), which will facilitate sustainability and nationwide dissemination, if effective. We hypothesize that compared with standard PAT monitoring and counseling (PAT), women randomized to the lifestyle intervention program (PAT+) will have a lower percentage who exceed Institute of Medicine recommendations for gestational weight gain.


Options:
A: Arm Label: advisory support; Type: EXPERIMENTAL; Interventions: Behavioral: advisory support | Intervention Type: BEHAVIORAL; Name: advisory support; Assigned to Arm(s): advisory support
B: Arm Label: Lifestyle Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Balance after Baby Lifestyle Intervention Program | Arm Label: Post-gestational diabetes mellitus (GDM) Follow-up Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Balance after Baby Lifestyle Intervention Program; Assigned to Arm(s): Lifestyle Intervention group
C: Arm Label: Education Home Visits; Type: EXPERIMENTAL; Interventions: Other: Education Home Visits | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education Home Visits; Assigned to Arm(s): Education Home Visits
D: Arm Label: Parents As Teachers + Lifestyle Int.; Type: EXPERIMENTAL; Interventions: Behavioral: Parents As Teachers Plus (PAT+) | Arm Label: Standard Parents as Teachers (PAT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Parents As Teachers (PAT) | Intervention Type: BEHAVIORAL; Name: Standard Parents As Teachers (PAT); Assigned to Arm(s): Standard Parents as Teachers (PAT) | Intervention Type: BEHAVIORAL; Name: Parents As Teachers Plus (PAT+); Assigned to Arm(s): Parents As Teachers + Lifestyle Int.

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the P.L.A.Y. Project Intervention for Autism
Brief Summary: This study is a large, multi-site, randomized controlled NIH trial that evaluates whether The P.L.A.Y. (Play and Language for Autistic Youngsters) Project is effective. The PLAY Project Home Consultation model coaches parents, through monthly home visits and the use of video feedback, to effectively interact with their young child with autism. The aims of the study are 1.) to show that the PLAY Home Consultants show fidelity to the model, 2.) that caregivers can be taught to interact in an engaging way with their child (with causing more stress), 3.) that the child then interacts better, improves his/her language, and has reduced severity of his or her autism.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
B: Arm Label: Pivotal Response Training (PRT); Type: EXPERIMENTAL; Interventions: Behavioral: Pivotal Response Training (PRT) | Arm Label: Parent Education Group (PEG); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Parent Education Group (PEG) | Intervention Type: BEHAVIORAL; Name: Pivotal Response Training (PRT); Assigned to Arm(s): Pivotal Response Training (PRT) | Intervention Type: BEHAVIORAL; Name: Parent Education Group (PEG); Assigned to Arm(s): Parent Education Group (PEG)
C: Arm Label: P.L.A.Y. Project Intervention for Autism; Type: EXPERIMENTAL; Interventions: Behavioral: PLAY Project Intervention for Autism | Arm Label: Special Education Pre-school; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Special education pre-school | Intervention Type: BEHAVIORAL; Name: PLAY Project Intervention for Autism; Assigned to Arm(s): P.L.A.Y. Project Intervention for Autism | Intervention Type: BEHAVIORAL; Name: Special education pre-school; Assigned to Arm(s): Special Education Pre-school
D: Arm Label: JAE-EMT; Type: EXPERIMENTAL; Interventions: Behavioral: JAE Intervention | Arm Label: JAE-AAC; Type: EXPERIMENTAL; Interventions: Behavioral: JAE Intervention | Intervention Type: BEHAVIORAL; Name: JAE Intervention; Assigned to Arm(s): JAE-AAC, JAE-EMT

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Randomized, Controlled Comparison of an Automated Thermal Pulsation Treatment (Lipiflow ®) and a Standard Lid Hygiene Regime
Brief Summary: Recently, beneficial effects on Meibomian gland dysfunction (MGD) of a single automated thermal pulsation with the Lipiflow® system have been reported in several case reports. In one study this treatment was compared with hyperthermia (iheat®) for 4 weeks. However, treatment recommendations for lid hygiene according to the MGD-report consist of hyperthermia followed by lid massage and lid margin cleansing over several months. To the best of the investigators knowledge this is the first randomized prospective study to compare automated thermal pulsation treatment with the new Lipiflow ® system with a standard lid hygiene regime.

The investigators suggest that a single treatment with Lipiflow® is superior to a lid hygiene regime.


Options:
A: Arm Label: LipiFlow group; Type: EXPERIMENTAL; Interventions: Device: LipiFlow Thermal pulsation system | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Eyelid warm compresses plus massages | Intervention Type: DEVICE; Name: LipiFlow Thermal pulsation system; Assigned to Arm(s): LipiFlow group | Intervention Type: PROCEDURE; Name: Eyelid warm compresses plus massages; Assigned to Arm(s): Control group
B: Arm Label: iLux; Type: EXPERIMENTAL; Interventions: Device: Systane iLux® Dry Eye System | Arm Label: LipiFlow; Type: ACTIVE_COMPARATOR; Interventions: Device: LipiFlow® Thermal Pulsation System | Intervention Type: DEVICE; Name: Systane iLux® Dry Eye System; Assigned to Arm(s): iLux | Intervention Type: DEVICE; Name: LipiFlow® Thermal Pulsation System; Assigned to Arm(s): LipiFlow
C: Arm Label: Standard Lid Hygiene Regime; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lid hygiene regime | Arm Label: Lipiflow; Type: ACTIVE_COMPARATOR; Interventions: Device: Lipiflow | Intervention Type: DEVICE; Name: Lipiflow; Assigned to Arm(s): Lipiflow | Intervention Type: BEHAVIORAL; Name: Lid hygiene regime; Assigned to Arm(s): Standard Lid Hygiene Regime
D: Arm Label: Normal; Type: N/A; Interventions: N/A | Arm Label: Dry Eye Disease; Type: N/A; Interventions: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Influence of Timing on Motor Learning
Brief Summary: The purpose of this research study is to compare different methods for training hand movement at home after stroke. This study involves research because it will test two experimental devices, the MusicGlove and the Resonating Arm Exerciser (RAE), compared to conventional hand and arm exercises. The MusicGlove is a glove that measures finger movements and allows its user to play a musical computer game using those movements. The RAE is a lever that attaches to a manual wheelchair with elastic bands and can be pushed back and forth to exercise the arm.


Options:
A: Arm Label: Virtual reality; Type: EXPERIMENTAL; Interventions: Device: Virtual Reality | Arm Label: Conventional arm training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional arm training | Intervention Type: DEVICE; Name: Virtual Reality; Assigned to Arm(s): Virtual reality | Intervention Type: BEHAVIORAL; Name: Conventional arm training; Assigned to Arm(s): Conventional arm training
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: robot therapy (ARMin) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional therapy | Intervention Type: DEVICE; Name: robot therapy (ARMin); Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: conventional therapy; Assigned to Arm(s): 2
C: Arm Label: Experimental Group (EG); Type: EXPERIMENTAL; Interventions: Device: Robot therapy (NeReBot), Other: Conventional therapy | Arm Label: Control Group (CG); Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional therapy | Intervention Type: DEVICE; Name: Robot therapy (NeReBot); Assigned to Arm(s): Experimental Group (EG) | Intervention Type: OTHER; Name: Conventional therapy; Assigned to Arm(s): Control Group (CG), Experimental Group (EG)
D: Arm Label: MusicGlove Group; Type: EXPERIMENTAL; Interventions: Device: MusicGlove | Arm Label: Control Group for Music Glove; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional hand exercise | Arm Label: Resonating Arm Exerciser (RAE); Type: EXPERIMENTAL; Interventions: Device: Resonating Arm Exerciser | Arm Label: Control Group for RAE; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Arm Exercise | Intervention Type: OTHER; Name: Conventional hand exercise; Assigned to Arm(s): Control Group for Music Glove | Intervention Type: DEVICE; Name: MusicGlove; Assigned to Arm(s): MusicGlove Group | Intervention Type: OTHER; Name: Conventional Arm Exercise; Assigned to Arm(s): Control Group for RAE | Intervention Type: DEVICE; Name: Resonating Arm Exerciser; Assigned to Arm(s): Resonating Arm Exerciser (RAE)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Open Label, Phase II Trial of Bevacizumab Plus Weekly Paclitaxel Followed by Bevacizumab Monotherapy Maintenance Versus Weekly Paclitaxel Followed by Observation in Patients With Relapsed Ovarian Sex-cord Stromal Tumours
Brief Summary: Bevacizumab (called also Avastin ®) is a medicine preventing the creation of new blood vessels (a process called "angiogenesis"). This can reduce blood flow of the tumor and then decreasing the contribution of nutriments and oxygen to the cancer cells and prevent the tumor from growing.

In various types of cancers, as lung, breast, colorectal and renal cancer, addition of the bevacizumab to chemotherapy allowed to improve the disease outcome. The bevacizumab already benefits from a marketing authorization (MMA) for these various types of cancers.

The bevacizumab has also obtained MMA for the treatment of the ovarian cancer in its most frequent histological form (ovarian carcinoma). Clinical trials conducted in this indication demonstrated the importance to pursue the treatment by bevacizumab after the chemotherapy is ended.

This anti-angiogenic medicine is thought to be of a potential interest in sex cords- stromal since this tumors are very well vascularized.

The ALIENOR study aims to explore the interest and the clinical benefit of associating bevacizumab to the paclitaxel in order to treat patients suffering from recurring sex cords- stromal tumor treated beforehand by platinum chemotherapy


Options:
A: Arm Label: BIBF 1120; Type: EXPERIMENTAL; Interventions: Drug: BIBF 1120, Drug: Paclitaxel, Drug: Carboplatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Paclitaxel, Drug: Carboplatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: BIBF 1120; Assigned to Arm(s): BIBF 1120 | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): BIBF 1120 | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): BIBF 1120
B: Arm Label: 1 non-continuous; Type: OTHER; Interventions: Drug: Sunitinib | Arm Label: 2 continuous; Type: OTHER; Interventions: Drug: SUNITINIB | Intervention Type: DRUG; Name: Sunitinib; Assigned to Arm(s): 1 non-continuous | Intervention Type: DRUG; Name: SUNITINIB; Assigned to Arm(s): 2 continuous
C: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Drug: Sorafenib | Intervention Type: DRUG; Name: Sorafenib; Assigned to Arm(s): Experimental
D: Arm Label: A - Paclitaxel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paclitaxel | Arm Label: B - Paclitaxel + Bevacizumab followed by Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Bevacizumab | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): A - Paclitaxel, B - Paclitaxel + Bevacizumab followed by Bevacizumab | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): B - Paclitaxel + Bevacizumab followed by Bevacizumab

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The objective of this study was to assess the relative effectiveness of reminder/recall strategies among children who live in an urban area targeting alternative age-specific milestones.


Options:
A: Arm Label: SMS Vaccine; Type: N/A; Interventions: Behavioral: SMS message reminding mothers to come for their scheduled vaccines | Arm Label: Usual care; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS message reminding mothers to come for their scheduled vaccines; Assigned to Arm(s): SMS Vaccine
B: Arm Label: Outreach; Type: OTHER; Interventions: Other: outreach services | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: outreach services; Assigned to Arm(s): Outreach
C: Arm Label: General Adolescent Vaccine Brochure; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Adolescent Vaccine Brochure | Arm Label: HPV brochure, recall, reminders; Type: EXPERIMENTAL; Interventions: Behavioral: HPV brochure, recall, reminders | Intervention Type: BEHAVIORAL; Name: HPV brochure, recall, reminders; Assigned to Arm(s): HPV brochure, recall, reminders | Intervention Type: BEHAVIORAL; Name: General Adolescent Vaccine Brochure; Assigned to Arm(s): General Adolescent Vaccine Brochure
D: Arm Label: No reminder / recall notice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mailed reminder / recall notice; Type: EXPERIMENTAL; Interventions: Behavioral: Childhood vaccination reminder / recall notification | Intervention Type: BEHAVIORAL; Name: Childhood vaccination reminder / recall notification; Assigned to Arm(s): mailed reminder / recall notice

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The objective of this study was to assess the relative effectiveness of reminder/recall strategies among children who live in an urban area targeting alternative age-specific milestones.


Options:
A: Arm Label: mailed reminder notice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mailed influenza vaccination reminder notice | Arm Label: No reminder notice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mailed influenza vaccination reminder notice; Assigned to Arm(s): mailed reminder notice
B: Arm Label: No reminder / recall notice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mailed reminder / recall notice; Type: EXPERIMENTAL; Interventions: Behavioral: Childhood vaccination reminder / recall notification | Intervention Type: BEHAVIORAL; Name: Childhood vaccination reminder / recall notification; Assigned to Arm(s): mailed reminder / recall notice
C: Arm Label: Historical Cohort; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Reminder Recall Outreach; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reminder-Recall-Outreach | Arm Label: Case Management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Case Management | Arm Label: Patient Navigation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient Navigator | Intervention Type: BEHAVIORAL; Name: Reminder-Recall-Outreach; Assigned to Arm(s): Reminder Recall Outreach | Intervention Type: BEHAVIORAL; Name: Case Management; Assigned to Arm(s): Case Management | Intervention Type: BEHAVIORAL; Name: Patient Navigator; Assigned to Arm(s): Patient Navigation
D: Intervention Type: DRUG; Name: Sulfadoxine pyrimethamine; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial to Evaluate the Impact of Using a Point-of-care Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients in Resource-poor Settings
Brief Summary: The novel urine LAM point-of-care strip test offers potential clinical utility to improve TB diagnosis in HIV co-infected patients. Urine LAM strip test performance improves with increasing illness severity and more advanced immunosuppression, thus offering the greatest potential utility in hospitalised HIV-infected patients with advanced immunosuppression (CD4 cell count less than 200). However, in the context of high rates of empiric treatment and the availability of other novel TB diagnostics, the clinical impact of the urine LAM strip test is unknown. This study will investigate the impact of the urine LAM strip test. The study hypothesis is that the urine LAM strip test, when combined with standard TB diagnostics (smear microscopy and culture) will significantly improve TB treatment-related outcomes (TB-related mortality, morbidity and length of hospital stay) in HIV-infected hospitalized patients when compared to standard TB diagnostics alone.


Options:
A: Arm Label: LAM plus standard care; Type: EXPERIMENTAL; Interventions: Device: Urine LAM strip test | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urine LAM strip test; Assigned to Arm(s): LAM plus standard care
B: Arm Label: Standard Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard treatment | Arm Label: Same-Day Treatment Group; Type: EXPERIMENTAL; Interventions: Other: Same-Day Treatment | Intervention Type: OTHER; Name: Same-Day Treatment; Assigned to Arm(s): Same-Day Treatment Group | Intervention Type: OTHER; Name: Standard treatment; Assigned to Arm(s): Standard Group
C: Intervention Type: OTHER; Name: Development of a diagnosis algorithm; Assigned to Arm(s): N/A
D: Arm Label: Centralised Xpert®Ultra testing; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Xpert Ultra Point of Care testing; Type: ACTIVE_COMPARATOR; Interventions: Diagnostic Test: Xpert Ultra Point of Care testing | Intervention Type: DIAGNOSTIC_TEST; Name: Xpert Ultra Point of Care testing; Assigned to Arm(s): Xpert Ultra Point of Care testing

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial to Evaluate the Impact of Using a Point-of-care Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients in Resource-poor Settings
Brief Summary: The novel urine LAM point-of-care strip test offers potential clinical utility to improve TB diagnosis in HIV co-infected patients. Urine LAM strip test performance improves with increasing illness severity and more advanced immunosuppression, thus offering the greatest potential utility in hospitalised HIV-infected patients with advanced immunosuppression (CD4 cell count less than 200). However, in the context of high rates of empiric treatment and the availability of other novel TB diagnostics, the clinical impact of the urine LAM strip test is unknown. This study will investigate the impact of the urine LAM strip test. The study hypothesis is that the urine LAM strip test, when combined with standard TB diagnostics (smear microscopy and culture) will significantly improve TB treatment-related outcomes (TB-related mortality, morbidity and length of hospital stay) in HIV-infected hospitalized patients when compared to standard TB diagnostics alone.


Options:
A: Intervention Type: OTHER; Name: No Intervention; Assigned to Arm(s): N/A
B: Arm Label: LAM plus standard care; Type: EXPERIMENTAL; Interventions: Device: Urine LAM strip test | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urine LAM strip test; Assigned to Arm(s): LAM plus standard care
C: Arm Label: Arm A: Empiric; Type: EXPERIMENTAL; Interventions: Drug: Atripla (r), Drug: Efavirenz, Drug: Truvada, Drug: Rifampin/isoniazid/pyrazinamide/ethambutol FDC, Drug: Rifampin/isoniazid FDC | Arm Label: Arm B: IPT; Type: EXPERIMENTAL; Interventions: Drug: Atripla (r), Drug: Efavirenz, Drug: Truvada, Drug: Isoniazid | Intervention Type: DRUG; Name: Atripla (r); Assigned to Arm(s): Arm A: Empiric, Arm B: IPT | Intervention Type: DRUG; Name: Efavirenz; Assigned to Arm(s): Arm A: Empiric, Arm B: IPT | Intervention Type: DRUG; Name: Truvada; Assigned to Arm(s): Arm A: Empiric, Arm B: IPT | Intervention Type: DRUG; Name: Rifampin/isoniazid/pyrazinamide/ethambutol FDC; Assigned to Arm(s): Arm A: Empiric | Intervention Type: DRUG; Name: Rifampin/isoniazid FDC; Assigned to Arm(s): Arm A: Empiric | Intervention Type: DRUG; Name: Isoniazid; Assigned to Arm(s): Arm B: IPT
D: Arm Label: Antiretroviral therapy, tuberculosis; Type: N/A; Interventions: N/A

Answer: B